AI Analysis AI Analysis of LLY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add LLY to Watchlist?
Some Reasons Why To Add LLY:
  • High gross margin of 83.5%
  • Beat earnings estimates in 3 of the last 4 quarters
  • Strong operating margin of 45.9%
PDF

Eli Lilly stock downgraded from Buy Candidate to Hold/Accumulate after Wednesday trading session
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since May 11, 2026 Gain 12.01%

The Eli Lilly stock price gained 1.73% on the last trading day (Wednesday, 3rd Jun 2026), rising from $1,064.84 to $1,083.23. During the last trading day the stock fluctuated 3.77% from a day low at $1,053.51 to a day high of $1,093.28. The price has risen in 6 of the last 10 days and is up by 6.03% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 199 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $2.14 billion.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.57% during the next 3 months and, with a 90% probability hold a price between $986.93 and $1,254.42 at the end of this 3-month period.

LLY Signals & Forecast

The Eli Lilly stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1,087.72. On a fall, the stock will find some support from the long-term average at approximately $982.11. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -3.93%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Eli Lilly stock

On the downside, the stock finds support just below today's level from accumulated volume at $954.28 and $934.34. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Eli Lilly finds support just below today's level at $954.28. If this is broken, then the next support from accumulated volume will be at $934.34 and $930.51.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $39.77 between high and low, or 3.77%. For the last week, the stock has had daily average volatility of 3.74%.

Our recommended stop-loss: $1,029.09 (-5.00%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (LLY) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Eli Lilly and Company to open at $1,076.67, and during the day (based on 14 day Average True Range), to move between $1,066.70 and $1,099.76, which gives a possible trading interval of +/-$33.06 (+/-3.10%) up or down from last closing price. If Eli Lilly and Company takes out the full calculated possible swing range there will be an estimated 3.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1,083.73 (0.05%) than the support at $954.28 (11.90%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Eli Lilly and Company stock A Buy?

Eli Lilly holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.986 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $1,076.67 ( 0.605%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

LLY Performance

Trading levels for LLY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1,116.44 3.07%
R2 1,101.25 1.66%
R1 1,091.86 0.797%
Price 1,083.23
S1 1,061.48 -2.01%
S2 1,052.10 -2.87%
S3 1,036.91 -4.28%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1,127.56 4.09%
R2 1,105.44 2.05%
R1 1,083.73 0.0462%
Price 1,083.23
S1 954.28 -11.90%
S2 934.34 -13.75%
S3 930.51 -14.10%

LLY Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 04, 2026 May 15, 2026 Jun 10, 2026 $1.73 0.175%
2 Feb 13, 2026 Feb 13, 2026 Mar 10, 2026 $1.73 0.174%
3 Nov 14, 2025 Nov 14, 2025 Dec 10, 2025 $1.50 0.183%
4 Aug 15, 2025 Aug 15, 2025 Sep 10, 2025 $1.50 0.193%
5 May 05, 2025 May 16, 2025 Jun 10, 2025 $1.50 0.201%

FAQ

What is the symbol for Eli Lilly Stock and on which exchange is it traded?
The symbol for Eli Lilly is LLY and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Eli Lilly Stock?
Eli Lilly holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Eli Lilly Stock?
Eli Lilly Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eli Lilly Stock.

What's the current price of Eli Lilly Stock?
As of the end of day on the Jun 03, 2026, the price of an Eli Lilly (LLY) share was $1,083.23.

What is the 52-week high and low for Eli Lilly Stock?
The 52-week high for Eli Lilly Stock is $1,149.10 and the 52-week low is $623.78.

What is the market capitalization of Eli Lilly Stock?
As of the Jun 03, 2026, the market capitalization of Eli Lilly is 1.02T.

When is the next earnings date for Eli Lilly?
The upcoming earnings date for Eli Lilly is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE